Pfizer Fails to Best Sarepta With Early Data on DMD Gene Therapy

(Bloomberg) -- Pfizer Inc.’s experimental gene therapy for boys with Duchenne muscular dystrophy helped treat the underlying cause of the deadly disease in a small study, though it also triggered s...

Bloomberg Quint

Add BloombergQuint App to Home screen.